APA (7th ed.) Citation

Yang, X., Wang, X., Yang, Y., Li, Z., Chen, Y., Shang, S., & Wang, Y. (2023). DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming. Journal of Translational Medicine, 21(1), 1. https://doi.org/10.1186/s12967-023-04323-z

Chicago Style (17th ed.) Citation

Yang, Xuejiao, Xiao Wang, Ying Yang, Zhiyang Li, Yunshuo Chen, Siqi Shang, and Yueying Wang. "DNMT3A Mutation Promotes Leukemia Development Through NAM-NAD Metabolic Reprogramming." Journal of Translational Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12967-023-04323-z.

MLA (9th ed.) Citation

Yang, Xuejiao, et al. "DNMT3A Mutation Promotes Leukemia Development Through NAM-NAD Metabolic Reprogramming." Journal of Translational Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12967-023-04323-z.